Knowcell Biotechnology

Knowcell Biotechnology is a Shenzhen-based healthcare company specializing in personal genetic testing and laboratory services. Founded in 2015, the company utilizes advanced genetic sequencing technology to provide accurate health risk assessments and management solutions to its clients. In addition to its consumer-facing services, Knowcell supports academic and clinical research by providing high-quality biological samples, such as peripheral blood from healthy donors, for studies in oncology and immunology. The company has secured significant venture capital funding, including a Series A round led by BGI Co-Win and USUM Investment Group. Knowcell's operations are centered on enhancing health management efficiency through genomic insights and supporting the broader life sciences research ecosystem.